TY - JOUR AU - Millan, M. J. AU - Andrieux, A. AU - Bartzokis, G. AU - Cadenhead, K. AU - Dazzan, P. AU - Fusar-Poli, P. PY - 2016 DA - 2016// TI - Altering the course of schizophrenia: progress and perspectives JO - Nat Rev Drug Discov VL - 15 UR - https://doi.org/10.1038/nrd.2016.28 DO - 10.1038/nrd.2016.28 ID - Millan2016 ER - TY - JOUR AU - Harvey, P. D. AU - Koren, D. AU - Reichenberg, A. AU - Bowie, C. R. PY - 2006 DA - 2006// TI - Negative symptoms and cognitive deficits: what is the nature of their relationship? JO - Schizophr Bull VL - 32 UR - https://doi.org/10.1093/schbul/sbj011 DO - 10.1093/schbul/sbj011 ID - Harvey2006 ER - TY - JOUR AU - Ettinger, U. AU - Meyhofer, I. AU - Steffens, M. AU - Wagner, M. AU - Koutsouleris, N. PY - 2014 DA - 2014// TI - Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia JO - Front Psychiatr VL - 5 UR - https://doi.org/10.3389/fpsyt.2014.00018 DO - 10.3389/fpsyt.2014.00018 ID - Ettinger2014 ER - TY - JOUR AU - Matza, L. S. AU - Buchanan, R. AU - Purdon, S. AU - Brewster-Jordan, J. AU - Zhao, Y. AU - Revicki, D. A. PY - 2006 DA - 2006// TI - Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment JO - Schizophr Bull VL - 32 UR - https://doi.org/10.1093/schbul/sbl004 DO - 10.1093/schbul/sbl004 ID - Matza2006 ER - TY - JOUR AU - Carpenter, W. T. AU - Koenig, J. I. PY - 2008 DA - 2008// TI - The evolution of drug development in schizophrenia: past issues and future opportunities JO - Neuropsychopharmacology VL - 33 UR - https://doi.org/10.1038/sj.npp.1301639 DO - 10.1038/sj.npp.1301639 ID - Carpenter2008 ER - TY - JOUR AU - Bruno, A. AU - Pandolfo, G. AU - Crucitti, M. AU - Lorusso, S. AU - Zoccali, R. A. AU - Muscatello, M. R. PY - 2016 DA - 2016// TI - Acetyl-L-Carnitine augmentation of Clozapine in partial-responder schizophrenia: a 12-week, open-label uncontrolled preliminary study JO - Clin Neuropharmacol VL - 39 UR - https://doi.org/10.1097/WNF.0000000000000170 DO - 10.1097/WNF.0000000000000170 ID - Bruno2016 ER - TY - JOUR AU - Mahadik, S. P. AU - Mukherjee, S. PY - 1996 DA - 1996// TI - Free radical pathology and antioxidant defense in schizophrenia: a review JO - Schizophr Res VL - 19 UR - https://doi.org/10.1016/0920-9964(95)00049-6 DO - 10.1016/0920-9964(95)00049-6 ID - Mahadik1996 ER - TY - JOUR AU - Reddy, R. D. AU - Yao, J. K. PY - 1996 DA - 1996// TI - Free radical pathology in schizophrenia: a review JO - Prostaglandins Leukot Essent Fatty Acids VL - 55 UR - https://doi.org/10.1016/S0952-3278(96)90143-X DO - 10.1016/S0952-3278(96)90143-X ID - Reddy1996 ER - TY - JOUR AU - Wu, J. Q. AU - Kosten, T. R. AU - Zhang, X. Y. PY - 2013 DA - 2013// TI - Free radicals, antioxidant defense systems, and schizophrenia JO - Prog Neuropsychopharmacol Biol Psychiatr VL - 46 UR - https://doi.org/10.1016/j.pnpbp.2013.02.015 DO - 10.1016/j.pnpbp.2013.02.015 ID - Wu2013 ER - TY - JOUR AU - Kleijnen, J. AU - Knipschild, P. PY - 1992 DA - 1992// TI - Ginkgo biloba JO - Lancet VL - 340 UR - https://doi.org/10.1016/0140-6736(92)93158-J DO - 10.1016/0140-6736(92)93158-J ID - Kleijnen1992 ER - TY - JOUR AU - Marcocci, L. AU - Packer, L. AU - Droy-Lefaix, M. T. AU - Sekaki, A. AU - Gardes-Albert, M. PY - 1994 DA - 1994// TI - Antioxidant action of Ginkgo Biloba extract EGb 761 JO - Methods Enzymol VL - 234 UR - https://doi.org/10.1016/0076-6879(94)34117-6 DO - 10.1016/0076-6879(94)34117-6 ID - Marcocci1994 ER - TY - JOUR AU - Knable, M. B. PY - 2002 DA - 2002// TI - Extract of Ginkgo Biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia JO - Evid Based Ment Health VL - 5 UR - https://doi.org/10.1136/ebmh.5.3.90 DO - 10.1136/ebmh.5.3.90 ID - Knable2002 ER - TY - JOUR AU - Doruk, A. AU - Uzun, O. AU - Ozsahin, A. PY - 2008 DA - 2008// TI - A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia JO - Int Clin Psychopharmacol VL - 23 UR - https://doi.org/10.1097/YIC.0b013e3282fcff2f DO - 10.1097/YIC.0b013e3282fcff2f ID - Doruk2008 ER - TY - JOUR AU - Chen, X. AU - Hong, Y. AU - Zheng, P. PY - 2015 DA - 2015// TI - Efficacy and safety of extract of Ginkgo Biloba as an adjunct therapy in chronic schizophrenia: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis JO - Psychiatry Res VL - 228 UR - https://doi.org/10.1016/j.psychres.2015.04.026 DO - 10.1016/j.psychres.2015.04.026 ID - Chen2015 ER - TY - JOUR AU - Huguet, F. AU - Drieu, K. AU - Piriou, A. PY - 1994 DA - 1994// TI - Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo Biloba extract (EGb 761) JO - J Pharm Pharmacol VL - 46 UR - https://doi.org/10.1111/j.2042-7158.1994.tb03802.x DO - 10.1111/j.2042-7158.1994.tb03802.x ID - Huguet1994 ER - TY - JOUR AU - Bolanos-Jimenez, F. AU - Manhaes de Castro, R. AU - Sarhan, H. AU - Prudhomme, N. AU - Drieu, K. AU - Fillion, G. PY - 1995 DA - 1995// TI - Stress-induced 5-HT1A receptor desensitization: protective effects of Ginkgo Biloba extract (EGb 761) JO - Fundam Clin Pharmacol VL - 9 UR - https://doi.org/10.1111/j.1472-8206.1995.tb00277.x DO - 10.1111/j.1472-8206.1995.tb00277.x ID - Bolanos-Jimenez1995 ER - TY - JOUR AU - White, H. L. AU - Scates, P. W. AU - Cooper, B. R. PY - 1996 DA - 1996// TI - Extracts of Ginkgo Biloba leaves inhibit monoamine oxidase JO - Life Sci VL - 58 UR - https://doi.org/10.1016/0024-3205(96)00097-5 DO - 10.1016/0024-3205(96)00097-5 ID - White1996 ER - TY - JOUR AU - Fowler, J. S. AU - Wang, G. J. AU - Volkow, N. D. AU - Logan, J. AU - Franceschi, D. AU - Franceschi, M. PY - 2000 DA - 2000// TI - Evidence that gingko biloba extract does not inhibit MAO a and B in living human brain JO - Life Sci VL - 66 UR - https://doi.org/10.1016/S0024-3205(99)00660-8 DO - 10.1016/S0024-3205(99)00660-8 ID - Fowler2000 ER - TY - JOUR AU - Huguet, F. AU - Tarrade, T. PY - 1992 DA - 1992// TI - Alpha 2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo Biloba extract JO - J Pharm Pharmacol VL - 44 UR - https://doi.org/10.1111/j.2042-7158.1992.tb14357.x DO - 10.1111/j.2042-7158.1992.tb14357.x ID - Huguet1992 ER - TY - JOUR AU - Amri, H. AU - Ogwuegbu, S. O. AU - Boujrad, N. AU - Drieu, K. AU - Papadopoulos, V. PY - 1996 DA - 1996// TI - In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo Biloba extract EGb 761 and isolated ginkgolides JO - Endocrinology VL - 137 UR - https://doi.org/10.1210/endo.137.12.8940403 DO - 10.1210/endo.137.12.8940403 ID - Amri1996 ER - TY - JOUR AU - Amri, H. AU - Drieu, K. AU - Papadopoulos, V. PY - 1997 DA - 1997// TI - Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo Biloba extract EGb 761 and isolated ginkgolide B JO - Endocrinology VL - 138 UR - https://doi.org/10.1210/endo.138.12.5604 DO - 10.1210/endo.138.12.5604 ID - Amri1997 ER - TY - JOUR AU - Marcilhac, A. AU - Dakine, N. AU - Bourhim, N. AU - Guillaume, V. AU - Grino, M. AU - Drieu, K. PY - 1998 DA - 1998// TI - Effect of chronic administration of Ginkgo Biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat JO - Life Sci VL - 62 UR - https://doi.org/10.1016/S0024-3205(98)00214-8 DO - 10.1016/S0024-3205(98)00214-8 ID - Marcilhac1998 ER - TY - JOUR AU - Holsboer, F. PY - 1999 DA - 1999// TI - The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety JO - J Psychiatr Res VL - 33 UR - https://doi.org/10.1016/S0022-3956(98)90056-5 DO - 10.1016/S0022-3956(98)90056-5 ID - Holsboer1999 ER - TY - JOUR AU - Spinella, M. AU - Eaton, L. A. PY - 2002 DA - 2002// TI - Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury JO - Brain Inj VL - 16 UR - https://doi.org/10.1080/02699050110103319 DO - 10.1080/02699050110103319 ID - Spinella2002 ER - TY - STD TI - Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;(4):CD000448. https://doi.org/10.1002/14651858.CD000448.pub3. ID - ref25 ER - TY - JOUR AU - Lingaerde, O. AU - Føreland, A. R. AU - Magnusson, A. PY - 1999 DA - 1999// TI - Can winter depression be prevented by Ginkgo Biloba extract? A placebo-controlled trial JO - Acta Psychiatr Scand VL - 100 UR - https://doi.org/10.1111/j.1600-0447.1999.tb10915.x DO - 10.1111/j.1600-0447.1999.tb10915.x ID - Lingaerde1999 ER - TY - JOUR AU - Bachinskaya, N. AU - Hoerr, R. AU - Ihl, R. PY - 2011 DA - 2011// TI - Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo Biloba extract EGb 761. Findings from a randomized controlled trial JO - Neuropsychiatr Dis Treat VL - 7 ID - Bachinskaya2011 ER - TY - JOUR AU - Scripnikov, A. AU - Khomenko, A. AU - Napryeyenko, O. PY - 2007 DA - 2007// TI - Effects of Ginkgo Biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial JO - Wien Med Wochenschr VL - 157 UR - https://doi.org/10.1007/s10354-007-0427-5 DO - 10.1007/s10354-007-0427-5 ID - Scripnikov2007 ER - TY - JOUR AU - DeFeudis, F. V. AU - Drieu, K. PY - 2000 DA - 2000// TI - Ginkgo Biloba extract (EGb 761) and CNS functions: basic studies and clinical applications JO - Curr Drug Targets VL - 1 UR - https://doi.org/10.2174/1389450003349380 DO - 10.2174/1389450003349380 ID - DeFeudis2000 ER - TY - JOUR AU - Heinonen, T. AU - Gaus, W. PY - 2015 DA - 2015// TI - Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo Biloba leaf extract JO - Toxicology VL - 327 UR - https://doi.org/10.1016/j.tox.2014.10.013 DO - 10.1016/j.tox.2014.10.013 ID - Heinonen2015 ER - TY - JOUR AU - Reininghaus, U. AU - Priebe, S. PY - 2012 DA - 2012// TI - Measuring patient-reported outcomes in psychosis: conceptual and methodological review JO - Br J Psychiatry VL - 201 UR - https://doi.org/10.1192/bjp.bp.111.107615 DO - 10.1192/bjp.bp.111.107615 ID - Reininghaus2012 ER - TY - JOUR AU - Takeuchi, H. AU - Fervaha, G. AU - Remington, G. PY - 2016 DA - 2016// TI - Reliability of a patient-reported outcome measure in schizophrenia: results from back-to-back self-ratings JO - Psychiatry Res VL - 244 UR - https://doi.org/10.1016/j.psychres.2016.07.055 DO - 10.1016/j.psychres.2016.07.055 ID - Takeuchi2016 ER - TY - JOUR AU - Hamera, E. K. AU - Schneider, J. K. AU - Potocky, M. AU - Casebeer, M. A. PY - 1996 DA - 1996// TI - Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders JO - Schizophr Res VL - 19 UR - https://doi.org/10.1016/0920-9964(95)00100-X DO - 10.1016/0920-9964(95)00100-X ID - Hamera1996 ER - TY - JOUR AU - Naranjo, C. A. AU - Busto, U. AU - Sellers, E. M. AU - Sandor, P. AU - Ruiz, I. AU - Roberts, E. A. PY - 1981 DA - 1981// TI - A method for estimating the probability of adverse drug reactions JO - Clin Pharmacol Ther VL - 30 UR - https://doi.org/10.1038/clpt.1981.154 DO - 10.1038/clpt.1981.154 ID - Naranjo1981 ER - TY - JOUR AU - Edwards, I. R. AU - Aronson, J. K. PY - 2000 DA - 2000// TI - Adverse drug reactions: definitions, diagnosis, and management JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02799-9 DO - 10.1016/S0140-6736(00)02799-9 ID - Edwards2000 ER -